Clinical Trials Logo

Filter by:
NCT ID: NCT01435200 Completed - Gynecologic Cancer Clinical Trials

Intravenous Iron in Gynecologic Cancer Patients Receiving Chemotherapy

Start date: June 2011
Phase: Phase 3
Study type: Interventional

Can intravenous iron lower the rate of blood transfusion in gynecologic cancer patients receiving platinum based chemotherapy than oral iron?

NCT ID: NCT01432678 Completed - Clinical trials for Vitamin D Deficiency

Vitamin D Status in Pediatric Asthma

Start date: April 2011
Phase: N/A
Study type: Observational

The purpose of this study is to evaluate level of vitamin D in pediatric asthma and relationship between vitamin D and level control of asthma.

NCT ID: NCT01432522 Completed - Anaphylaxis Clinical Trials

A Study for Absorption of Intranasal Epinephrine Compared to Conventional Intramuscular Epinephrine

Epinephrine
Start date: July 2010
Phase: N/A
Study type: Interventional

This study is a preliminary report of pharmacokinetic data of epinephrine administered via intranasal route (IN) comparing with intramuscular (IM) route in healthy adult volunteers.

NCT ID: NCT01430026 Completed - Chronic Sinusitis Clinical Trials

Efficacy and Complication of Gentamicin Nasal Irrigation in Chronic Rhinosinusitis

Start date: March 2011
Phase: N/A
Study type: Observational

The propose of this study to determine efficacy and complication of gentamicin nasal irrigation in chronic rhinosinusitis

NCT ID: NCT01429662 Completed - Hypertension Clinical Trials

Modified Relaxation (MR) Technique for Treating Hypertension in Postmenopausal Women

Start date: August 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate better effectiveness of modified relaxation (MR) technique over no MR for treating hypertension in Thai postmenopausal women.

NCT ID: NCT01429636 Completed - Hot Flashes Clinical Trials

Applied Relaxation (AR) Technique Versus Its Modified Version for Treating Menopausal Symptoms

Start date: August 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate better efficacy and effectiveness of modified applied relaxation technique over its original version for treating menopausal symptoms.

NCT ID: NCT01420341 Completed - Melioidosis Clinical Trials

Co-trimoxazole as Maintenance Therapy for Melioidosis

Start date: August 2011
Phase: Phase 4
Study type: Interventional

This is a randomised, open-labelled, controlled trial to compare the efficacy and effectiveness on relapse-free rate of 12-week versus 20-week oral eradication treatment of melioidosis. The study population includes 800 patients with culture-confirmed melioidosis whom 12 weeks of oral eradication therapy have been completed with or without intravenous intensive antibiotics. Patients will be randomised to either stop the eradication treatment or continue current oral treatment for 8 more weeks. The study aim to optimise the regimen used to treat melioidosis for better compliance and reducing unnecessary use of antibiotics.

NCT ID: NCT01408992 Completed - Hearing Loss Clinical Trials

Thai-version Five Minute Hearing Test

Thai_FMHT
Start date: July 2011
Phase: N/A
Study type: Interventional

This study is aimed to test the sensitivity and specificity of Thai-version Five Minutes Hearing test against the audiometry to screen hearing problem in community.

NCT ID: NCT01408537 Completed - Clinical trials for Encephalitis, Japanese B

Immunogenicity and Safety of Inactivated Vero Cell Derived Japanese Encephalitis Vaccine in Thai Children

JE0153
Start date: May 2010
Phase: Phase 3
Study type: Interventional

Japanese encephalitis (JE) is the main cause of viral encephalitis in many countries of Asia including Thailand. Estimated annual mortality ranges from10,000-15,000 deaths, while the total number of clinical cases is about 50,000. Of these cases, about 50% result in permanent neuropsychiatric sequelae. The disease occurs mostly among children aged <10 years. There is no specific antiviral treatment for JE. Vaccination is the single most important control measure. This study aims to evaluate the immunogenicity and safety of inactivated Vero cell derived JE vaccine (Beijing P-3 strain) produced by Liaoning Cheng Da Biotechnology Co., Ltd, China "JEVAC" in Thai children. 152 healthy Thai children aged between 1-3 years will be vaccinated with "JEVAC" in a dose of 0.5 mL. subcutaneously on Day 0, 1-4 weeks later and a booster vaccination at one year (totally 3 doses). Two mL. of blood will be drawn on Day 0, 4 weeks after second dose, at one year on booster vaccination day and 4 weeks after the booster (totally 8 mL. of 13 months study period) for determination of JE neutralizing antibodies (PRNT50) using Beijing P3 strain. Adverse events will be observed for 28 days after each vaccination. Serious adverse events will be observed throughout the study period.

NCT ID: NCT01406912 Completed - Ischemic Stroke Clinical Trials

Efficacy of Virtual Reality Exercises in STroke Rehabilitation: A Multicentre Study (EVREST Multicentre)

Start date: July 2011
Phase: N/A
Study type: Interventional

A multicentre, randomized, two parallel group study comparing virtual reality using Wii gaming technology versus Recreational activities in patients receiving conventional rehabilitation after an ischemic stroke. Primary Hypothesis: Virtual reality using the Wii gaming system is more efficacious in improving motor function than recreational therapy among patients receiving conventional rehabilitation following a recent ischemic stroke.